Position in AMGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$323,373
New position
Shares Held
893
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#2,504
of 3,140 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Anchor Bay Capital, Inc. holds $6,690,065 across 9 Drug Manufacturers - General names. AMGN ranks #7 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
15,355 | $1,939,950 | |
| 2 | MRK |
Merck & Co., Inc.
|
12,598 | $1,618,843 | |
| 3 | ABBV |
AbbVie Inc.
|
3,689 | $928,299 | |
| 4 | GSK |
GSK plc
|
16,193 | $848,837 | |
| 5 | JNJ |
Johnson & Johnson
|
2,088 | $530,289 | |
| 6 | PFE |
Pfizer Inc
|
19,965 | $480,757 | |
| 7 | AMGN |
Amgen Inc
This page
|
893 | $323,373 | |
| 8 | LLY |
ELI LILLY & Co
|
16 | $19,190 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,373 | 893 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||